Abstract:Purpose of review: Opioid receptors are widely expressed in the human brain. A number of features commonly associated with drug use disorder, such as difficulties in emotional learning, emotion regulation and anhedonia, have been linked to endogenous opioid signalling. Whereas chronic substance use and misuse are thought to alter the function of the mu-opioid system, the specific mechanisms are not well understood. We argue that understanding exogenous and endogenous opioid effects in the healthy human brain is an essential foundation for bridging preclinical and clinical findings related to opioid misuse. Here, we will examine psychopharmacological evidence to outline the role of the mu-opioid receptor (MOR) system in the processing of threat and reward, and discuss how disruption of these processes by chronic opioid use might alter emotional learning and reward responsiveness. Recent findings: In healthy people, studies using opioid antagonist drugs indicate that the brain's endogenous opioids downregulate fear reactivity and upregulate learning from safety. At the same time, endogenous opioids increase the liking of and motivation to engage with high reward value cues. Studies of acute opioid agonist effects indicate that with non-sedative doses, drugs such as morphine and buprenorphine can mimic endogenous opioid effects on liking and wanting. Disruption of endogenous opioid signalling due to prolonged opioid exposure is associated with some degree of anhedonia to non-drug rewards; however, new results leave open the possibility that this is not directly opioid-mediated. Summary: The available human psychopharmacological evidence indicates that the healthy mu-opioid system contributes to the regulation of reward and threat processing. Overall, endogenous opioids can subtly increase liking and wanting responses to a wide variety of rewards, from sweet tastes to feelings of being connected to close others. For threat-related processing, human evidence suggests that endogenous opioids inhibit fear conditioning and reduce the sensitivity to aversive stimuli, although inconsistencies remain. The size of effects reported in healthy humans are however modest, clearly indicating that MORs play out their role in close concert with other neurotransmitter systems. Relevant candidate systems for future research include dopamine, serotonin and endocannabinoid signalling. Nevertheless, it is possible that endogenous opioid fine-tuning of reward and threat processing, when unbalanced by e.g. opioid misuse, could over time develop into symptoms associated with opioid use disorder, such as anhedonia and depression/anxiety.

Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity

Exploratory study of associations between monetary reward anticipation brain responses and mu-opioid signalling in alcohol dependence, gambling disorder and healthy controls

Neurophysiological activity following gains and losses among young adults with non-suicidal self-injury: An ERP study

External error monitoring in subclinical obsessive-compulsive subjects: electrophysiological evidence from a Gambling Task

Feedback related negativity event-related potentials in heroin addicts

Dysfunctional Feedback Processing in Adolescent Males with Conduct Disorder.

The Study of Feedback-related Negativity Responses in Adolescents with Conduct Disorder

The subjective experience of heroin effects among individuals with chronic opioid use: Revisiting reinforcement in an exploratory study

Is Monetary Reward Processing Altered in Drug-Naïve Youth with a Behavioral Addiction? Findings from Internet Gaming Disorder

Sensitivity to Monetary Reward in Drug Abstainers at Different Post-drug Withdrawal Phases: An ERP Study

Blunted sensitivity to expected value during risky decision making in individuals with problematic pornography use

Differential gene expression and chromatin accessibility in the medial prefrontal cortex associated with individual differences in rat behavioral models of opioid use disorder

Alterations in surface-based brain morphometry in men with opioid use disorder

Case-control Study of Error-Related Negativity among Males with Heroin Dependence Undergoing Rehabilitation.

The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies

Regional Cerebral Metabolism Alterations and Functional Connectivity in Individuals with Opioid Use Disorder: an Integrated Resting-State PET/fMRI Study.

Dysfunctional feedback processing in male methamphetamine abusers: Evidence from neurophysiological and computational approaches

Modulation of Attentional Bias to Drug and Affective Cues by Therapeutic and Neuropsychological Factors in Patients With Opioid Use Disorder on Methadone Maintenance Therapy

Smaller Feedback-Related Negativity (FRN) Reflects the Risky Decision-Making Deficits of Methamphetamine Dependent Individuals

Differentiating the Abnormalities of Social and Monetary Reward Processing Associated with Depressive Symptoms

Blunted stimulus-preceding negativity during reward anticipation in major depressive disorder